Rola serotoniny w padaczce nieświadomości: wpływ na sieć talamusu i kory mózgowej oraz receptory serotoniny

PubMed➕ 30.10.2026Acta Neurol Taiwan

Serotonergic Modulation in Absence Epilepsy: The Role of Thalamo-cortical Networks and 5-hydroxytryptamine Receptors

W skrócie

Badanie dotyczy padaczki nieświadomości, czyli drgawek, podczas których pacjent krótko traci świadomość. Naukowcy zbadali, jak substancja zwana serotoninę wpływa na pracę mózgu podczas tych drgawek, szczególnie poprzez różne receptory serotoniny. Wyniki pokazują, że niektóre receptory serotoniny mogą zmniejszać drgawki, ale dotychczas nie ma dowodów, aby zmienić obecne leczenie tej choroby.

Oryginalny abstract (angielski)

Absence epilepsy is characterized by brief nonconvulsive seizures and generalized spike-and-wave discharges (SWDs) generated within distributed cortico-thalamo-cortical networks. Although the roles of T-type calcium channels, GABAergic inhibition, and network synchronization are well established, serotonergic modulation of these circuits remains incompletely defined. This review integrates evidence from genetic and pharmacological animal models, receptor signaling and distribution studies, human neurophysiological and neuroimaging investigations, clinical observations, and emerging receptor-selective approaches. The available evidence indicates that serotonergic effects are determined by receptor subtype, anatomical and cellular localization, developmental stage, and experimental model. Activation of 5-HT2C receptors generally suppresses SWDs, potentially by reducing excessive tonic GABA-A inhibition in thalamocortical neurons, whereas 5-HT7 receptor antagonism reduces SWDs in WAG/Rij rats, although its underlying cellular mechanism remains uncertain. In contrast, 5-HT1A receptor modulation produces bidirectional, model-dependent effects, and thalamic 5-HT2A receptor activation may either suppress or facilitate absence activity depending on the functional state of the network. Evidence concerning 5-HT3, 5-HT4, 5-HT5, and 5-HT6 receptors is sparse. Globally acting serotonergic antidepressants also show heterogeneous effects in preclinical models, and human data do not establish an antiabsence benefit. Preliminary findings from an open-label Phase 2 study of the selective 5-HT2C agonist BMB-101 are insufficient to determine clinical efficacy. Overall, receptor-selective serotonergic mechanisms offer mechanistic insight and potential investigational targets, particularly 5-HT2C and 5-HT7 receptors; however, current evidence does not support altering established absence epilepsy treatment. Controlled clinical studies and developmentally appropriate translational models are required.

Metadane publikacji

Journal
Acta Neurol Taiwan
Data publikacji
01.10.2026
PMID
42954437
DOI
10.4103/ant.ANT-D-26-00044
Autorzy
Aktemur BH, Saltık ÖD
Słowa kluczowe
5-hydroxytryptamine receptors, absence epilepsy, neurophysiology, serotonin, thalamocortical networks
Źródło
PubMed